For diabetes or off-label weight loss (Ozempic dosing schedule): 0.25 mg for four weeks, then 0.5 mg ongoing
Semaglutide produces real, measurable effects, but timelines and magnitudes vary based on dose, individual factors, diet, and activity levels
Unimolecular multi-specific agonist peptides targeting multiple incretin pathways have emerged as promising therapeutic strategies for weight loss 7,8,18,19,20,21,22,23,24,25,26
We found that the inflammatory factors, Il-1, Il-6, Cxcl15 , and Tnf- , which are related to aging, were significantly decreased in the aging-related secretory phenotype (Figure 1B)